N. H. Andersen, T. L. Eggerman, L. A. Harker, and C. H. Wilson, On the multiplicity of platelet prostaglandin receptors I. Evaluation of competitive antagonism by aggregometry, Prostaglandins, vol.19, issue.5, pp.19-711, 1980.
DOI : 10.1016/0090-6980(80)90170-7

K. Schrör and M. Braun, Platelets as a source of vasoactive mediators, Review. Stroke, vol.12, pp.32-35, 1990.

D. R. Janero, Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury, Free Radical Biology and Medicine, vol.9, issue.6, pp.515-540, 1990.
DOI : 10.1016/0891-5849(90)90131-2

8. Hydroxyheptadeca-5z, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2

M. I. Siegel, R. T. Mcconnel, N. Porter, P. Cuatrecasas, R. W. Bryant et al., Arachidonate metabolism via lipoxygenase and 12L-hydroperoxy-5,8,10,14-icosatetraenoic acid peroxidase sensitive to anti-inflammatory drugs., Proceedings of the National Academy of Sciences, vol.77, issue.1, pp.308-312, 1980.
DOI : 10.1073/pnas.77.1.308
URL : http://www.pnas.org/content/77/1/308.full.pdf

P. Falardeau, M. Hamberg, and B. Samuelsson, 14-eicosatrienoic acid in human platelets, Biochim Biophys Acta, vol.811, issue.441, pp.193-200, 1976.
DOI : 10.1016/0005-2760(76)90162-4

D. Boukhchache and M. Lagarde, Interactions between prostaglandin precursors during their oxygenation by human platelets, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.713, issue.2, pp.386-392, 1982.
DOI : 10.1016/0005-2760(82)90257-0

M. Lagarde, A. Gharib, and M. Dechavanne, Different utilization of arachidonic and dihomogammalinolenic acids by human platelet prostaglandin synthetase, Biochimie, vol.59, issue.11-12, pp.59-935, 1977.
DOI : 10.1016/S0300-9084(78)80710-X

M. Vanrollins, L. Horrocks, and H. Sprecher, Metabolism of 7,10,13,16-docosatetraenoic acid to dihomo-thromboxane12-nonadecatrienoic acid and hydroxy fatty acids by human platelets, Biochim Biophys Acta, vol.14710, issue.833, pp.272-280, 1985.

I. Morita, R. Takahashi, Y. Saito, and S. Murota, Stimulation of eicosapentaenoic acid metabolism in washed human platelets by 12-hydroperoxyeicosatetraenoic acid, J Biol Chem, pp.258-10197, 1983.

M. Lagarde, M. Burtin, H. Sprecher, M. Dechavanne, and S. Renaud, Potentiating effect of 5,8,11-eicosatrienoic acid on human platelet aggregation, Lipids, vol.6, issue.4, pp.18-291, 1983.
DOI : 10.1016/0005-2760(77)90188-6

E. Prostaglandin and . Activity, platelet lipoxygenase end-product, FEBS Lett, vol.20, issue.181, pp.3-9, 1985.

L. Mcgregor, R. Morazain, and S. Renaud, A comparison of the effects of dietary short and long chain saturated fatty acids on platelet functions, platelet phospholipids, and blood coagulation in rats, Lab Invest, pp.43-438, 1980.

M. Croset, J. C. Bordet, and M. Lagarde, Inhibition of prostaglandin H synthase and activation of 12-lipoxygenase by 8,11,14,17-eicosatetraenoic acid in human endothelial cells and platelets, Biochemical Pharmacology, vol.57, issue.6, pp.631-638, 1999.
DOI : 10.1016/S0006-2952(98)00334-7

M. I. Aveldaño and H. Sprecher, Synthesis of hydroxy fatty acids from 4, pp.13-16

M. Croset, A. Sala, G. Folco, and M. Lagarde, Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle, Biochemical Pharmacology, vol.37, issue.7, pp.1275-1280, 1988.
DOI : 10.1016/0006-2952(88)90782-4

J. W. Karanian, H. Y. Kim, T. Shingu, J. A. Yergey, A. Yoffe et al., Smooth muscle effects of hydroxylated docosahexaenoates produced from human platelet, Biomed Biochim Acta, pp.47-79, 1988.

S. Hong, Y. Lu, H. Tian, B. V. Alapure, B. A. Wang et al., Maresin-like Lipid Mediators Are Produced by Leukocytes and Platelets and Rescue Reparative Function of Diabetes-Impaired Macrophages, Chemistry & Biology, vol.21, issue.10, pp.1318-1329, 2014.
DOI : 10.1016/j.chembiol.2014.06.010

M. Guichardant and M. Lagarde, Studies on platelet lipoxygenase specificity towards icosapolyenoic and docosapolyenoic acids, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.836, issue.2, pp.210-214, 1985.
DOI : 10.1016/0005-2760(85)90068-2

J. W. Karanian, H. Y. Kim, and N. Salem-jr, The structure-activity relationship of lipoxygenase products of long-chain polyunsaturated fatty acids: Effects on human platelet aggregation, Lipids, vol.117, issue.1, pp.31-305, 1996.
DOI : 10.1139/y86-012

G. Kaur, D. Cameron-smith, A. J. Garg, and . Sinclair, Docosapentaenoic acid (22:5n-3): A review of its biological effects, Progress in Lipid Research, vol.50, issue.1, pp.28-34, 2011.
DOI : 10.1016/j.plipres.2010.07.004

J. Dalli, R. A. Colas, and C. N. Serhan, Novel n-3 immunoresolvents: structures and functions. Sci Rep, 1940.
DOI : 10.1038/srep01940
URL : http://www.nature.com/articles/srep01940.pdf

D. Daret, P. Blin, and J. Larrue, Synthesis of hydroxy fatty acids from linoleic acid by human blood platelets, Prostaglandins, vol.38, issue.2, pp.203-221, 1989.
DOI : 10.1016/0090-6980(89)90083-X

W. R. Henderson-jr, M. Rashed, E. C. Yong, T. R. Fritsche, and G. K. Chiang, Toxoplasma gondii stimulates the release of 13- and 9-hydroxyoctadecadienoic acids by human platelets, Biochemistry, vol.31, issue.23, pp.31-5356, 1992.
DOI : 10.1021/bi00138a016

M. R. Buchanan, T. A. Haas, M. Lagarde, and M. Guichardant, 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX, J Biol Chem, vol.260, pp.16056-16059, 1985.

M. A. Tloti, D. G. Moon, L. K. Weston, and J. E. Kaplan, Effect of 13-hydroxyoctadeca-9,11-dienoic acid (13-hode) on thrombin induced platelet adherence to endothelial cells in vitro, Thrombosis Research, vol.62, issue.4, pp.305-317, 1991.
DOI : 10.1016/0049-3848(91)90151-L

M. Hamberg, 12-octadecatrienoic acid in human platelets, Biochem Biophys Res Commun, vol.6, issue.117, pp.593-600, 1983.

M. Liu, P. Chen, E. Véricel, M. Lelli, L. Béguin et al., Characterization and biological effects of di-hydroxylated compounds deriving from the lipoxygenation of ALA, Journal of Lipid Research, vol.259, issue.1 Suppl., pp.2083-2094, 2013.
DOI : 10.1073/pnas.91.8.3228
URL : https://hal.archives-ouvertes.fr/inserm-00832286

M. Lagarde, E. Véricel, M. Liu, P. Chen, and M. Guichardant, Structure-function relationships of non-cyclic dioxygenase products from polyunsaturated fatty acids: Poxytrins as a class of bioactive derivatives, Biochimie, vol.107, pp.91-94, 2014.
DOI : 10.1016/j.biochi.2014.09.008
URL : https://hal.archives-ouvertes.fr/inserm-01072459

P. Chen, E. Véricel, M. Lagarde, and M. Guichardant, Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation, The FASEB Journal, vol.258, issue.1, pp.382-388, 2011.
DOI : 10.1016/0006-2952(89)90422-X
URL : https://hal.archives-ouvertes.fr/inserm-00517396

R. Murray and G. A. Fitzgerald, Regulation of thromboxane receptor activation in human platelets., Proceedings of the National Academy of Sciences, vol.86, issue.1, pp.124-128, 1989.
DOI : 10.1073/pnas.86.1.124

M. Hirata, Y. Hayashi, F. Ushikubi, Y. Yokota, R. Kageyama et al., Cloning and expression of cDNA for a human thromboxane A2 receptor, Nature, vol.349, issue.6310, pp.349-617, 1991.
DOI : 10.1038/349617a0

A. Shenker, P. Goldsmith, C. G. Unson, and A. M. Spiegel, The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family, J Biol Chem, vol.266, pp.9309-9313, 1991.

J. J. Baldassare, A. P. Tarver, P. A. Henderson, W. M. Mackin, B. Sahagan et al., Reconstitution of thromboxane A2 receptor-stimulated phosphoinositide hydrolysis in isolated platelet membranes: involvement of phosphoinositide-specific phospholipase C-beta and GTP-binding protein Gq, Biochem J, pp.291-235, 1993.

D. C. Mills and D. E. Macfarlane, Stimulation of human platelet adenylate cyclase by prostaglandin D2, Thrombosis Research, vol.5, issue.3, pp.401-412, 1974.
DOI : 10.1016/0049-3848(74)90176-5

R. A. Armstrong, Platelet prostanoid receptors, Pharmacology & Therapeutics, vol.72, issue.3, pp.171-191, 1996.
DOI : 10.1016/S0163-7258(96)00103-9

M. O. Whitaker, A. Wyche, F. Fitzpatrick, H. Sprecher, and P. Needleman, Triene prostaglandins: Prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances, Proceedings of the National Academy of Sciences, vol.76, issue.11, pp.76-5919, 1979.
DOI : 10.1073/pnas.76.11.5919
URL : http://www.pnas.org/content/76/11/5919.full.pdf

H. H. Tai, C. M. Ensor, M. Tong, H. Zhou, and F. Yan, Prostaglandin catabolizing enzymes, Prostaglandins & Other Lipid Mediators, vol.68, issue.69, pp.483-493, 2002.
DOI : 10.1016/S0090-6980(02)00050-3

M. Aldrovandi, V. J. Hammond, H. Podmore, M. Hornshaw, S. R. Clark et al., Human platelets generate phospholipid-esterified prostaglandins via cyclooxygenase-1 that are inhibited by low dose aspirin supplementation, Journal of Lipid Research, vol.83, issue.11, pp.3085-3097, 2013.
DOI : 10.1529/biophysj.107.112565
URL : http://www.jlr.org/content/54/11/3085.full.pdf

P. Fonlupt, M. Croset, and M. Lagarde, 12-HETE inhibits the binding of PGH2/TxA2 receptor ligands in human platelets, Thrombosis Research, vol.63, issue.2, pp.239-248, 1991.
DOI : 10.1016/0049-3848(91)90287-7

M. R. Buchanan, P. Horsewood, and S. J. Brister, Regulation of endothelial cell and platelet receptor-ligand binding by the 12- and 15-lipoxygenase monohydroxides, 12-, 15-HETE and 13-HODE, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.58, issue.5, pp.58-339, 1998.
DOI : 10.1016/S0952-3278(98)90069-2

R. Vanhove and . Grée, Further studies on the anti-thromboxane A2 activity of monohydroxylated fatty acids, Biochem Pharmacol, vol.38, pp.1863-1864, 1989.

C. Schneider and A. R. Brash, Stereospecificity of hydrogen abstraction in the conversion of arachidonic acid to 15R-HETE by aspirin-treated cyclooxygenase-2. Implications for the alignment of substrate in the active site, J Biol Chem, pp.275-4743, 2000.

R. W. Bryant and J. M. Bailey, Altered lipoxygenase metabolism and decreased glutathione peroxidase activity in platelets from selenium-deficient rats, Biochemical and Biophysical Research Communications, vol.92, issue.1, pp.92-268, 1980.
DOI : 10.1016/0006-291X(80)91548-X

. Visioli, Oxygen free radicals and myocardial damage: protective role of thiol-containing agents, Am J Med. Review, vol.91, pp.95-105, 1991.

W. C. Chang, J. Nakao, H. Orimo, and S. Murota, Effects of reduced glutathione on the 12-lipoxygenase pathways in rat platelets, Biochemical Journal, vol.202, issue.3, pp.771-776, 1982.
DOI : 10.1042/bj2020771

M. I. Siegel, R. T. Mcconnell, S. L. Abrahams, N. A. Porter, and P. Cuatrecasas, Regulation of arachidonate metabolism via lipoxygenase and cyclo-oxygenase by 12-HPETE, the product of human platelet lipoxygenase, Biochemical and Biophysical Research Communications, vol.89, issue.4, pp.891-1273
DOI : 10.1016/0006-291X(79)92146-6

M. Croset and M. Lagarde, Enhancement of eicosaenoic acid lipoxygenation in human platelets by 12-hydroperoxy derivative of arachidonic acid, Lipids, vol.10, issue.11, pp.743-750, 1985.
DOI : 10.1016/0005-2760(82)90257-0

C. Calzada, E. Vericel, and M. Lagarde, Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation, Biochemical Journal, vol.325, issue.2, pp.495-500, 1997.
DOI : 10.1042/bj3250495

C. Tournier, G. Thomas, J. Pierre, C. Jacquemin, M. Pierre et al., Mediation by Arachidonic Acid Metabolites of the H2O2-Induced Stimulation of Mitogen-Activated Protein Kinases (Extracellular-Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase), European Journal of Biochemistry, vol.91, issue.2, pp.587-595, 1997.
DOI : 10.1074/jbc.270.15.8377

L. Coulon, C. Calzada, P. Moulin, E. Véricel, and M. Lagarde, Activation of P38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets, Free Radical Biology and Medicine, vol.35, issue.6, pp.616-625, 2003.
DOI : 10.1016/S0891-5849(03)00386-1

N. Bernoud-hubac, D. A. Alam, J. Lefils, S. S. Davies, V. Amarnath et al., Low concentrations of reactive gamma-ketoaldehydes prime thromboxane-dependent human platelet aggregation via p38-MAPK activation, Biochim Biophys Acta, pp.1791-307, 2009.

M. Lagarde and . Guichardant, Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals, J Lipid Res, vol.48, pp.816-825, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00139399

V. , D. Marzo, L. De-petrocellis, N. Sepe, and A. Buono, Biosynthesis of anandamide and

E. Véricel, C. Januel, M. Carreras, P. Moulin, and M. Lagarde, Diabetic Patients Without Vascular Complications Display Enhanced Basal Platelet Activation and Decreased Antioxidant Status, Diabetes, vol.53, issue.4, pp.53-1046, 2004.
DOI : 10.2337/diabetes.53.4.1046

E. Ponsin, M. Véricel, and . Lagarde, In vitro glycoxidized low-density lipoproteins and lowdensity lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogenactivated protein kinase, J Clin Endocrinol Metab, vol.92, pp.1961-1964, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00267256

C. Lagarde and . Calzada, LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets, Diabetologia, vol.54, pp.2931-2940, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00616814

G. S. Mcmahon, C. I. Jones, P. D. Hayes, A. R. Naylor, and A. H. , Transient heparininduced platelet activation linked to generation of platelet 12-lipoxygenase. Findings from a randomised controlled trial, Thromb Haemost, vol.109, pp.2099-2107, 2013.

B. Porro, P. Songia, I. Squellerio, E. Tremoli, and V. Cavalca, Analysis, physiological and clinical significance of 12-HETE: A neglected platelet-derived 12-lipoxygenase product, Journal of Chromatography B, vol.964, pp.26-40, 2014.
DOI : 10.1016/j.jchromb.2014.03.015

R. De-schrijver, D. Vermeulen, and V. Daems, Dose-Response Relationships between Dietary (n-3) Fatty Acids and Plasma and Tissue Lipids, Steroid Excretion and Urinary Malondialdehyde in Rats, The Journal of Nutrition, vol.122, issue.10, pp.1979-1987, 1992.
DOI : 10.1093/jn/122.10.1979

F. Driss, E. Véricel, M. Lagarde, M. Dechavanne, and P. Darcet, Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid, Thrombosis Research, vol.36, issue.5, pp.3893-3896, 1984.
DOI : 10.1016/0049-3848(84)90295-0

M. Croset, E. Véricel, M. Rigaud, M. Hanss, P. Courpron et al., Functions and tocopherol content of blood platelets from elderly people after low intake of purified eicosapentaenoic acid, Thrombosis Research, vol.57, issue.1, pp.57-58, 1990.
DOI : 10.1016/0049-3848(90)90190-N

C. Calzada, E. Véricel, and M. Lagarde, Lower levels of lipid peroxidation in human platelets incubated with eicosapentaenoic acid, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1127, issue.2, pp.1127-147, 1992.
DOI : 10.1016/0005-2760(92)90270-6

E. Véricel, A. Polette, S. Bacot, C. Calzada, and M. Lagarde, Pro- and antioxidant activities of docosahexaenoic acid on human blood platelets, Journal of Thrombosis and Haemostasis, vol.279, issue.3, pp.566-572, 2003.
DOI : 10.1001/jama.279.1.23

L. J. Roberts-2nd, J. D. Morrow, and . Isoprostanes, Isoprostanes., Annals of the New York Academy of Sciences, vol.327, issue.1 Cellular Gene, pp.237-242, 1994.
DOI : 10.1016/0168-8278(90)90123-9

N. Guillot, E. Caillet, M. Laville, C. Calzada, M. Lagarde et al., Increasing intakes of the long-chain ??-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men, The FASEB Journal, vol.23, issue.9, pp.2909-2916, 2009.
DOI : 10.1016/j.plefa.2006.05.014
URL : https://hal.archives-ouvertes.fr/inserm-00387440

C. Calzada, R. Colas, N. Guillot, M. Guichardant, M. Laville et al., Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men, Atherosclerosis, vol.208, issue.2, pp.467-472, 2010.
DOI : 10.1016/j.atherosclerosis.2009.07.049
URL : https://hal.archives-ouvertes.fr/inserm-00416728

E. Véricel, R. Colas, C. Calzada, Q. H. Lê, N. Feugier et al., Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients, Thromb Haemost, vol.114, pp.289-296, 2015.

. Bellon, Moderate intake of docosahexaenoic acid raises plasma and platelet vitamin E levels in cystic fibrosis patients, Prostaglandins Leukot Essent Fatty Acids, vol.115, pp.41-47, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01409665

L. G. Wood, D. A. Fitzgerald, and M. L. Garg, Hypothesis: Vitamin E Complements Polyunsaturated Fatty Acids in Essential Fatty Acid Deficiency in Cystic Fibrosis, Journal of the American College of Nutrition, vol.25, issue.4, pp.253-257, 2003.
DOI : 10.1016/S0889-8553(05)70255-7

S. Moncada, E. A. Higgs, and R. M. Palmer, Characterization and biological significance of endothelium-derived relaxing factor, Biochemical Society Transactions, vol.16, issue.4, pp.484-486, 1988.
DOI : 10.1042/bst0160484

D. Pastori, P. Pignatelli, R. Carnebale, and F. Visioli, Nox-2 up-regulation and platelet activation: Novel insights, Prostaglandins & Other Lipid Mediators, vol.120, pp.50-55, 2015.
DOI : 10.1016/j.prostaglandins.2015.03.010

E. Fuentes and I. Palomo, Role of oxidative stress on platelet hyperreactivity during aging, Life Sciences, vol.148, pp.17-23, 2016.
DOI : 10.1016/j.lfs.2016.02.026